New research highlighted at a symposium during an Annual Meeting ForFamily Physicians shows how nicotine withdrawal from quitting smoking affectscognitive performance (such as ability to concentrate) when trying to quit.Further, brain imaging shows that when treatment with the commit(R) 4 mglozenge is introduced, these symptoms of nicotine withdrawal can be reversed.This new research may help physicians gain a better understanding of nicotineaddiction and how treatment can help.
Advertisement
These new data demonstrate that the commit 4 mg lozenge increasesactivity in regions of the brain affected by nicotine withdrawal compared tono treatment. Researchers believe it would be of interest to see how othersmoking cessation treatments perform in similar studies.
Advertisement
ADDITIONAL RESOURCES: Video, contact information and more available at:http://www.prnewswire.com/broadcast/34593/press.html
VIDEO PROVIDED BY: GLAXOSMITHKLINE
Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations,1-800-653-5313 EXT. 3For more information visit: www.commitlozenge.com or www.way2quit.com SATELLITE FEEDS: Thursday, September 18th, 2008 Friday, September 19th, 2008 1:00 PM - 1:15 PM ET 10:00 AM - 10:15 AM ET AMC 3 Galaxy 25 C-Band C-Band Transponder 3 Transponder 13 Downlink Freq. 3760 Horizontal Downlink Freq. 3960 Vertical NEWS: Research Highlights Effects of Smoking On The Brain FORMAT: B-roll and Soundbites
SOURCE GLAXOSMITHKLINE
